Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone makes the connections in the uterus lining simpler and lowers certain protein levels, which might lead to infertility.

NISCH syndrome is a rare genetic disorder affecting skin and liver, with variable symptoms and limited treatment options.

Topical 4-aminopyridine 5% does not improve hair growth in male pattern baldness.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Current guidelines may overlook beard and sideburn involvement in diagnosing frontal fibrosing alopecia in men.

Menopause can cause oral health issues like dry mouth and burning sensations.

Compound 7p shows strong potential as an anticancer agent.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Five new mutations in the androgen receptor gene were found, helping to understand androgen insensitivity syndrome better.

A gene network led by RSL4 is crucial for early root hair growth in response to cold in Arabidopsis thaliana.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

Claudin-1 is important for the barrier function and growth of hair.

Claudin-1 and Claudin-3 are crucial for keeping hair follicle structure and preventing a type of hair loss called telogen effluvium.

Finasteride treatment changes Cx43 in rat testes, possibly causing fertility issues.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

HAT-L4 is crucial for preventing body fluid loss by maintaining skin barrier integrity.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Mast cells play a significant role in hair loss conditions like male pattern hair loss and alopecia areata.

400 nm particles penetrate hair follicles best, but mouse models aren't fully reliable for human studies.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

The hair treatment made hair grow faster and thicker and strengthened the hair roots.

Claudin-1 is crucial for maintaining skin barrier and preventing inflammation.

Claudin expression changes help the skin respond to injury.

Folliculin deficiency causes problems with cell division and positioning due to disrupted RhoA signaling and interaction with p0071.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

TLR4 is important in aging-related diseases and could be a new treatment target.